Temporally resolved proteomics identifies nidogen-2 as a cotarget in pancreatic cancer that modulates fibrosis and therapy response
Pereira, Brooke A, Ritchie, Shona, Chambers, Cecilia R, Gordon, Katie A, Magenau, Astrid, Murphy, Kendelle J, Nobis, Max, Tyma, Victoria M, Liew, Ying Fei, Lucas, Morghan C, Naeini, Marjan M, Barkauskas, Deborah S, Chacon-Fajardo, Diego, Howell, Anna E, Parker, Amelia L, Warren, Sean C, Reed, Daniel A, Lee, Victoria, Metcalf, Xanthe L, Lee, Young Kyung, O'Regan, Luke P, Zhu, Jessie, Trpceski, Michael, Fontaine, Angela R M, Stoehr, Janett, Rouet, Romain, Lin, Xufeng, Chitty, Jessica L, Porazinski, Sean, Wu, Sunny Z, Filipe, Elysse C, Cadell, Antonia L, Holliday, Holly, Yang, Jessica, Papanicolaou, Michael, Lyons, Ruth J, Zaratzian, Anaiis, Tayao, Michael, Da Silva, Andrew, Vennin, Claire, Yin, Julia, Dew, Alysha B, McMillan, Paul J, Goldstein, Leonard D, Deveson, Ira W, Croucher, David R, Samuel, Michael S, Sim, Hao-Wen, Batten, Marcel, Chantrill, Lorraine, Grimmond, Sean M, Gill, Anthony J, Samra, Jaswinder, Jeffry Evans, Thomas R, Sasaki, Takako, Phan, Tri G, Swarbrick, Alexander, Sansom, Owen J, Morton, Jennifer P, Pajic, Marina, Parker, Benjamin L, Herrmann, David, Cox, Thomas R, Timpson, Paul
Published in Science advances (05.07.2024)
Published in Science advances (05.07.2024)
Get full text
Journal Article